Effects of control interventions on Clostridium difficile infection in England: an observational study.
Dingle, K. E., Didelot, X., Quan, T. P., Eyre, D. W., Stoesster, N., Golubchik, T., Harding, R. M., Wilson, D. J., Griffiths, D., Oakley, S. J., the Modernising Medical Microbiology Informatics Group, Fawley, W. N., Freeman, J., Morris, K., Martin, J., Howard, P., Gorbach, S., Goldstein, E. J. C., Citron, D. M., Hopkins, S., Hope, R., Johnson, A. P., Wilcox, M. H., Peto, T. E. A., Walker, A. S. and D. W. Crook (2017)
Lancet Infectious Diseases 17: 411-421. (pdf)
The control of Clostridium difficile infections is an international clinical challenge. The incidence of C difficile in England declined by roughly 80% after 2006, following the implementation of national control policies; we tested two hypotheses to investigate their role in this decline. First, if C difficile infection declines in England were driven by reductions in use of particular antibiotics, then incidence of C difficile infections caused by resistant isolates should decline faster than that caused by susceptible isolates across multiple genotypes. Second, if C difficile infection declines were driven by improvements in hospital infection control, then transmitted (secondary) cases should decline regardless of susceptibility.
Regional (Oxfordshire and Leeds, UK) and national data for the incidence of C difficile infections and antimicrobial prescribing data (1998-2014) were combined with whole genome sequences from 4045 national and international C difficile isolates. Genotype (multilocus sequence type) and fluoroquinolone susceptibility were determined from whole genome sequences. The incidence of C difficile infections caused by fluoroquinolone-resistant and fluoroquinolone-susceptible isolates was estimated with negative-binomial regression, overall and per genotype. Selection and transmission were investigated with phylogenetic analyses.
National fluoroquinolone and cephalosporin prescribing correlated highly with incidence of C difficile infections (cross-correlations >0.88), by contrast with total antibiotic prescribing (cross-correlations <0.59). Regionally, C difficile decline was driven by elimination of fluoroquinolone-resistant isolates (approximately 67% of Oxfordshire infections in September, 2006, falling to approximately 3% in February, 2013; annual incidence rate ratio 0.52, 95% CI 0.48-0.56 vs fluoroquinolone-susceptible isolates: 1.02, 0.97-1.08). C difficile infections caused by fluoroquinolone-resistant isolates declined in four distinct genotypes (p<0.01). The regions of phylogenies containing fluoroquinolone-resistant isolates were short-branched and geographically structured, consistent with selection and rapid transmission. The importance of fluoroquinolone restriction over infection control was shown by significant declines in inferred secondary (transmitted) cases caused by fluoroquinolone-resistant isolates with or without hospital contact (p<0.0001) versus no change in either group of cases caused by fluoroquinolone-susceptible isolates (p>0.2).
Restricting fluoroquinolone prescribing appears to explain the decline in incidence of C difficile infections, above other measures, in Oxfordshire and Leeds, England. Antimicrobial stewardship should be a central component of C difficile infection control programmes.